Equities Analysts Offer Predictions for MOH Q2 Earnings

Key Points

• Zacks Research lowered Molina Healthcare’s Q2 2027 EPS estimate to $2.38 from $2.39 and maintains a “Hold” rating; its full-year consensus earnings estimate is $5.28 per share.
• Molina’s latest quarter exceeded expectations, with EPS of $1.51 versus the $1.39 consensus and revenue of $10.87 billion, although revenue declined 4.8% year over year and the company reported a nearly breakeven net margin.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating from 17 analysts and a $202.44 price target, compared with its recent opening price of $209.71.

Molina Healthcare, Inc (NYSE:MOH - Free Report) - Analysts at Zacks Research reduced their Q2 2027 earnings estimates for Molina Healthcare in a research note issued to investors on Tuesday, October 13th. Zacks Research analyst Team now expects that the company will earn $2.38 per share for the quarter, down from their prior estimate of $2.39. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Molina Healthcare's current full-year earnings is $5.28 per share. Zacks Research also issued estimates for Molina Healthcare's Q1 2028 earnings at $2.85 EPS and FY2028 earnings at $12.19 EPS.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.12. The firm had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%. The business's revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the company posted $5.48 earnings per share.

MOH has been the subject of a number of other reports. Truist Financial decreased their price objective on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating for the company in a research report on Friday, July 24th. Weiss Ratings lowered Molina Healthcare from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, October 6th. Wall Street Zen lowered Molina Healthcare from a "hold" rating to a "sell" rating in a report on Sunday, October 4th. Sanford C. Bernstein set a $286.00 price target on Molina Healthcare in a research note on Monday, July 13th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating on shares of Molina Healthcare in a report on Friday, October 9th. Three investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $202.44.

Molina Healthcare Stock Up 0.1%

MOH opened at $209.71 on Thursday. The business has a 50 day moving average price of $198.92 and a two-hundred day moving average price of $192.75. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. The company has a market cap of $10.95 billion, a PE ratio of -1,164.96, a P/E/G ratio of 30.04 and a beta of 0.78. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $244.89.

Institutional Investors Weigh In On Molina Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Fortitude Family Office LLC lifted its holdings in Molina Healthcare by 63.7% in the 3rd quarter. Fortitude Family Office LLC now owns 131 shares of the company's stock valued at $25,000 after purchasing an additional 51 shares in the last quarter. Physician Wealth Advisors Inc. lifted its stake in shares of Molina Healthcare by 1,250.0% during the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company's stock worth $29,000 after purchasing an additional 200 shares during the period. SJS Investment Consulting Inc. lifted its stake in shares of Molina Healthcare by 504.9% during the 1st quarter. SJS Investment Consulting Inc. now owns 248 shares of the company's stock worth $33,000 after purchasing an additional 207 shares during the period. Elevation Wealth Partners LLC lifted its stake in shares of Molina Healthcare by 118.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company's stock worth $33,000 after purchasing an additional 78 shares during the period. Finally, Global Retirement Partners LLC acquired a new stake in shares of Molina Healthcare during the second quarter worth $39,000. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare News Roundup

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Shares recently outperformed competitors during a strong trading session, and Zacks Research continues to maintain a “Strong-Buy” view in several of its estimate reports. The stock is also trading above its 50-day and 200-day moving averages, indicating relatively firm recent momentum. Molina Healthcare stock outperforms competitors on strong trading day
• Neutral Sentiment: Molina Healthcare is projected to report quarterly results on Wednesday. Investors will focus on whether membership trends, medical costs and government-program economics support the expected earnings recovery. Molina Healthcare projected to post quarterly earnings
• Negative Sentiment: Zacks Research downgraded MOH from “Strong-Buy” to “Hold,” citing a less favorable earnings outlook. It reduced its Q3 2026 EPS estimate to $0.70 from $0.71 and lowered its FY2026 forecast to $5.25 from $5.27, compared with a broader consensus estimate of $5.29. Analysts estimate Molina to report a decline in earnings
• Negative Sentiment: The firm also trimmed FY2027 EPS to $9.24 from $9.28 and made smaller cuts to several 2027–2028 quarterly estimates. Although these reductions are modest, they reinforce concerns that the anticipated earnings recovery is taking longer than expected.
• Negative Sentiment: A Seeking Alpha analysis argues that Molina is valued at roughly 21 times expected earnings despite the recovery not yet being evident, creating downside risk if upcoming results or guidance disappoint. Molina Healthcare paying for a recovery that has not happened yet

About Molina Healthcare

Molina Healthcare, Inc is a managed-care company that provides health insurance and related healthcare services primarily to individuals and families who receive coverage through government-sponsored programs. Its main lines of business include Medicaid, Medicare, and health plans offered through government marketplaces.

The company works with state and federal agencies, healthcare providers, and community organizations to coordinate care for members, including low-income adults and children, seniors, and people with disabilities or complex medical needs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.